[1] |
Grossniklaus HE. Retinoblastoma. Fifty years of progress. The LXXI Edward Jackson Memorial Lecture[J]. Am J Ophthalmol, 2014, 158(5): 875-891.
|
[2] |
Dimaras H, Corson TW, Cobrinik D, et al. Retinoblastoma[J]. Nature reviews Disease primers, 2015, 1(1): 1-23.
|
[3] |
Chen M, Jiang H, Zhang J, et al. Outcome of intra-arterial chemotherapy for retinoblastoma and its influencing factors:a retrospective study[J]. Acta Ophthalmol, 2017, 95(6): 613-618.
|
[4] |
Manjandavida FP, Stathopoulos C, Zhang J, et al. Intra-arterial chemotherapy in retinoblastoma–a paradigm change[J]. Indian Journal of Ophthalmology, 2019, 67(6): 740-754.
|
[5] |
Sweid A, Hammoud B, Weinberg JH, et al. Ophthalmic artery catheterization for retinoblastoma treatment: does reflux affect tumor response?[J]. Journal of NeuroInterventional Surgery, 2020, 12(9): 915-920.
|
[6] |
Yamane T, Kaneko A, Mohri M. The technique of ophthalmic arterial infusion therapy for patients with intraocular retinoblastoma[J]. Int J Clin Oncol, 2004, 9(2): 69-73.
|
[7] |
Pham CT, Blanc R, Rouic LLL, et al. Access to the ophthalmic artery by retrograde approach through the posterior communicating artery for intra-arterial chemotherapy of retinoblastoma[J]. Neuroradiology, 2012, 54(8): 845-848.
|
[8] |
Saglam M, Sarici A, Anagnostakou V, et al. An alternative technique of the superselective catheterization of the ophthalmic artery for intra-arterial chemotherapy of the retinoblastoma: retrograde approach through the posterior communicating artery to the ophthalmic artery[J]. Neuroradiology, 2014, 56(9): 751-754.
|
[9] |
Stathopoulos C, Bartolini B, Marie G, et al. Risk factors for acute choroidal ischemia after intra-arterial melphalan for retinoblastoma: the role of the catheterization approach[J]. Ophthalmology, 2021, 128(5): 754-764.
|
[10] |
Ancona-Lezama D, Dalvin LA, Lucio-Alvarez JA, et al. Ophthalmic vascular events after intra-arterial chemotherapy for retinoblastoma: real-world comparison between primary and secondary treatments[J]. Retina, 2019, 39(12): 2264-2272.
|
[11] |
Sweid A, El Naamani K, Sajja KC, et al. Incidence and predictors of ophthalmic artery occlusion in intra-arterial chemotherapy for retinoblastoma[J]. Journal of NeuroInterventional Surgery, 2021, 13(7): 652-656.
|
[12] |
Stathopoulos C, Bartolini B, Marie G, et al. Risk factors for acute choroidal ischemia after intra-arterial melphalan for retinoblastoma: the role of the catheterization approach[J]. Ophthalmology, 2021, 128(5): 754-764.
|
[13] |
Wang L, Han M, Zhao J, et al. Intra-arterial chemotherapy for unilateral advanced intraocular retinoblastoma: results and short-term complications[J]. Medicine, 2018, 97(42):e12676.
|